Nanjing Well Pharmaceutical Group Co.,Ltd.
603351.SS · Shanghai Stock Exchange · CNY
28,42CNY
+1,09 (+3,99 %)Stand 10. Nov., 7:00
Kennzahlen
- Eröffnung
- 27,35
- Vortag
- 27,33
- Tagesspanne
- 27,31 – 28,57
- 52 Wochen
- 21,90 – 30,80
- Volumen
- 2,94 Mio.
- Ø Volumen
- 1,78 Mio.
- Börsenwert
- 3,85 Mrd. CNY
- KGV
- –
- Gewinn je Aktie (TTM)
- –
- Dividendenrendite
- –
- Beta
- 0,1
- Nächste Zahlen
- –
Finanzen
Gerade nicht verfügbar.
Bewertung
Gerade nicht verfügbar.
Analysten
Einstufungen
Gerade nicht verfügbar.
Kursziel
Gerade nicht verfügbar.
Quartalszahlen
Gerade nicht verfügbar.
Dividenden und Splits
Gerade nicht verfügbar.
Aktiensplits
Gerade nicht verfügbar.
Eigentümer
Institutionen
Gerade nicht verfügbar.
Insider-Geschäfte
Gerade nicht verfügbar.
Vergleichbare Unternehmen
Gerade nicht verfügbar.
Über das Unternehmen
Nanjing Well Pharmaceutical Group Co., Ltd., founded in 2000 and headquartered in Nanjing, China, is primarily engaged in the research, development, manufacturing, and distribution of pharmaceutical excipients within the Chinese market. These essential auxiliary materials are utilized in both injectable and non-injectable drug formulations. Beyond its pharmaceutical focus, the company also supplies an extensive range of synthetic base oils for various industrial applications, including hydraulic fluids, lubricity additives for metals, metal quenching agents, compression lubricants, gear oils, chain lubricants, and base stocks for engine oils, heat transfer oils, and greases. Furthermore, its product portfolio diversifies into other specialized chemicals such as paints and coatings, textile chemicals, field chemicals, and low-foam metal cleaners. The company boasts a global presence, exporting its products to key markets in Europe, the United States, Southeast Asia, and other international regions. Originally known as Nanjing Well Pharmaceutical Co., Ltd., the company officially adopted its current name, Nanjing Well Pharmaceutical Group Co., Ltd., in April 2020.
- CEO
- Renrong Wu
- Mitarbeitende
- 718
- Hauptsitz
- Nanjing, JS, CN
- Sektor
- Healthcare
- Branche
- Drug Manufacturers - Specialty & Generic
- Börsengang
- 30. Jan. 2019
- Website
- wellnj.com
Nachrichten
Gerade nicht verfügbar.
Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.